Effects of TGF-β signaling in clear cell renal cell carcinoma cells

Biochemical and Biophysical Research Communications

Volumn 435, Issue 1, 2013, Pages 126-133

  Boström, Anna Karin ^a   Lindgren, David ^a   Johansson, Martin E ^a   Axelson, Håkan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Invasion; Microarray; Renal cell carcinoma; TGF signaling; Von Hippel Lindau (VHL)

Indexed keywords

ACTIN; HYPOXIA INDUCIBLE FACTOR; NOTCH RECEPTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CELL INVASION; CONTROLLED STUDY; CYTOKINE RELEASE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HYPOXIA; IN VITRO STUDY; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR INVASION; WESTERN BLOTTING;

BENZAMIDES; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DIOXOLES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84878186292     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.04.054     Document Type: Article

References (39)

1. Rini B.I., Campbell S.C., Escudier B. Renal cell carcinoma. Lancet 2009, 373:1119-1132.
2. Kovacs G., Akhtar M., Beckwith B.J., Bugert P., Cooper C.S., Delahunt B., Eble J.N., Fleming S., Ljungberg B., Medeiros L.J., Moch H., Reuter V.E., Ritz E., Roos G., Schmidt D., Srigley J.R., Storkel S., van den Berg E., Zbar B. The Heidelberg classification of renal cell tumours. J. Pathol. 1997, 183:131-133.
3. Kim W.Y., Kaelin W.G. Role of VHL gene mutation in human cancer. J. Clin. Oncol. 2004, 22:4991-5004.
4. Freeburg P.B., Abrahamson D.R. Divergent expression patterns for hypoxia-inducible factor-1beta and aryl hydrocarbon receptor nuclear transporter-2 in developing kidney. J. Am. Soc. Nephrol. 2004, 15:2569-2578.
5. 2 sensing. Science 2001, 292:464-468.
6. 2-regulated prolyl hydroxylation. Science 2001, 292:468-472.
7. Rankin E.B., Tomaszewski J.E., Haase V.H. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res. 2006, 66:2576-2583.
8. Latif F., Tory K., Gnarra J., Yao M., Duh F.M., Orcutt M.L., Stackhouse T., Kuzmin I., Modi W., Geil L., et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993, 260:1317-1320.
9. Mandriota S.J., Turner K.J., Davies D.R., Murray P.G., Morgan N.V., Sowter H.M., Wykoff C.C., Maher E.R., Harris A.L., Ratcliffe P.J., Maxwell P.H. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 2002, 1:459-468.
10. Cohen H.T., McGovern F.J. Renal-cell carcinoma. N. Engl. J. Med. 2005, 353:2477-2490.
11. Moustakas A., Heldin C.H. The regulation of TGFbeta signal transduction. Development 2009, 136:3699-3714.
12. Massague J., Gomis R.R. The logic of TGFbeta signaling. FEBS Lett. 2006, 580:2811-2820.
13. Padua D., Massague J. Roles of TGFbeta in metastasis. Cell Res. 2009, 19:89-102.
14. Hegele A., Varga Z., von Knobloch R., Heidenreich A., Kropf J., Hofmann R. TGF-beta1 in patients with renal cell carcinoma. Urol. Res. 2002, 30:126-129.
15. Mitropoulos D., Kiroudi A., Christelli E., Serafetinidis E., Zervas A., Anastasiou I., Dimopoulos C. Expression of transforming growth factor beta in renal cell carcinoma and matched non-involved renal tissue. Urol. Res. 2004, 32:317-322.
16. Ananth S., Knebelmann B., Gruning W., Dhanabal M., Walz G., Stillman I.E., Sukhatme V.P. Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma. Cancer Res. 1999, 59:2210-2216.
17. Sjolund J., Bostrom A.K., Lindgren D., Manna S., Moustakas A., Ljungberg B., Johansson M., Fredlund E., Axelson H. The notch and TGF-beta signaling pathways contribute to the aggressiveness of clear cell renal cell carcinoma. PLoS One 2011, 6:e23057.
18. Bostrom A.K., Moller C., Nilsson E., Elfving P., Axelson H., Johansson M.E. Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition. Hum. Pathol. 2012, 43:708-719.
19. Lindgren D., Bostrom A.K., Nilsson K., Hansson J., Sjolund J., Moller C., Jirstrom K., Nilsson E., Landberg G., Axelson H., Johansson M.E. Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am. J. Pathol. 2011, 178:828-837.
20. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. Article3.
21. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102:15545-15550.
22. Coulouarn C., Factor V.M., Thorgeirsson S.S. Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer. Hepatology 2008, 47:2059-2067.
23. Kennedy B.A., Deatherage D.E., Gu F., Tang B., Chan M.W., Nephew K.P., Huang T.H., Jin V.X. ChIP-seq defined genome-wide map of TGFbeta/SMAD4 targets: implications with clinical outcome of ovarian cancer. PLoS One 2011, 6:e22606.
24. Padua D., Zhang X.H., Wang Q., Nadal C., Gerald W.L., Gomis R.R., Massague J. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 2008, 133:66-77.
25. Schodel J., Oikonomopoulos S., Ragoussis J., Pugh C.W., Ratcliffe P.J., Mole D.R. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 2011, 117:e207-217.
26. Zhao H., Ljungberg B., Grankvist K., Rasmuson T., Tibshirani R., Brooks J.D. Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med 2006, 3:e13.
27. Sievers E., Albers P., Schmidt-Wolf I.G., Marten A. Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma. J. Urol. 2004, 171:114-119.
28. Thiery J.P. Epithelial-mesenchymal transitions in cancer onset and progression. Bull. Acad. Natl. Med. 2009, 193:1969-1978. discussion 1978-1969.
29. Wendt M.K., Allington T.M., Schiemann W.P. Mechanisms of the epithelial-mesenchymal transition by TGF-beta. Future Oncol. 2009, 5:1145-1168.
30. Miyajima A., Asano T., Seta K., Kakoi N., Hayakawa M. Loss of expression of transforming growth factor-beta receptor as a prognostic factor in patients with renal cell carcinoma. Urology 2003, 61:1072-1077.
31. Copland J.A., Luxon B.A., Ajani L., Maity T., Campagnaro E., Guo H., LeGrand S.N., Tamboli P., Wood C.G. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression. Oncogene 2003, 22:8053-8062.
32. Ku J.L., Park S.H., Yoon K.A., Shin Y.K., Kim K.H., Choi J.S., Kang H.C., Kim I.J., Han I.O., Park J.G. Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-beta-induced transcriptional activation. Cancer Lett. 2007, 247:283-292.
33. Chen F., Cai W., Chen Z., Liu R. Establishment of a method for detecting transforming growth factor beta 1 mRNA. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1998, 16:219-222.
34. Zhang H., Akman H.O., Smith E.L., Zhao J., Murphy-Ullrich J.E., Batuman O.A. Cellular response to hypoxia involves signaling via Smad proteins. Blood 2003, 101:2253-2260.
35. Falanga V., Qian S.W., Danielpour D., Katz M.H., Roberts A.B., Sporn M.B. Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts. J. Invest. Dermatol. 1991, 97:634-637.
36. Norman J.T., Clark I.M., Garcia P.L. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int. 2000, 58:2351-2366.
37. Sanchez-Elsner T., Botella L.M., Velasco B., Corbi A., Attisano L., Bernabeu C. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 2001, 276:38527-38535.
38. Sanchez-Elsner T., Ramirez J.R., Sanz-Rodriguez F., Varela E., Bernabeu C., Botella L.M. A cross-talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SP1 and Smads. J. Mol. Biol. 2004, 336:9-24.
39. Basu R.K., Hubchak S., Hayashida T., Runyan C.E., Schumacker P.T., Schnaper H.W. Interdependence of HIF-1alpha and TGF-beta/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression. Am. J. Physiol. Renal. Physiol. 2011, 300:F898-F905.